Enoblituzumab, previously known as TJ-271 or MGA271, represents the innovative antibody specific to CD33, the antigen found predominantly on cancer tissues. This antibody operates as the two-pronged construct, https://cormacbjdw081142.blog-gold.com/58686754/enoblituzumab-a-deep-dive-into-tj-271-and-mga271